NO883594D0 - Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. - Google Patents

Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Info

Publication number
NO883594D0
NO883594D0 NO883594A NO883594A NO883594D0 NO 883594 D0 NO883594 D0 NO 883594D0 NO 883594 A NO883594 A NO 883594A NO 883594 A NO883594 A NO 883594A NO 883594 D0 NO883594 D0 NO 883594D0
Authority
NO
Norway
Prior art keywords
various
procedure
preparation
rna preparations
double wired
Prior art date
Application number
NO883594A
Other languages
English (en)
Other versions
NO883594L (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO883594D0 publication Critical patent/NO883594D0/no
Publication of NO883594L publication Critical patent/NO883594L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO88883594A 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. NO883594L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (2)

Publication Number Publication Date
NO883594D0 true NO883594D0 (no) 1988-08-12
NO883594L NO883594L (no) 1989-02-13

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883594A NO883594L (no) 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Country Status (19)

Country Link
EP (1) EP0308066B1 (no)
JP (1) JPH01131119A (no)
KR (1) KR0131879B1 (no)
CN (1) CN1050995C (no)
AT (1) ATE132041T1 (no)
AU (3) AU2053588A (no)
CA (1) CA1327002C (no)
DE (1) DE3854829T2 (no)
DK (1) DK449888A (no)
FI (1) FI883763A (no)
HU (1) HUT47854A (no)
IE (1) IE72103B1 (no)
IL (1) IL87413A0 (no)
NO (1) NO883594L (no)
NZ (1) NZ225799A (no)
OA (1) OA08901A (no)
PT (1) PT88266B (no)
RU (1) RU1834663C (no)
ZA (1) ZA885967B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
WO1989011285A1 (en) * 1988-05-23 1989-11-30 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用dsRNA
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
BR9007741A (pt) * 1989-10-11 1992-08-11 Hem Res Inc Protecao contra estados de choque subsequentes a lesoes por rnas de duplo filamento
DE69029737T2 (de) * 1989-10-16 1997-06-19 Hem Pharma Corp Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch-immunologischer fehlfunktion
AU2554792A (en) * 1991-09-26 1993-04-27 Hem Pharmaceuticals Corp. Method of neutralizing il-1 using dsrnas
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CZ295108B6 (cs) 1998-03-20 2005-05-18 Benitec Australia Ltd Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP2314700A1 (en) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
JP5578388B2 (ja) * 2002-04-18 2014-08-27 オプコ ファーマシューティカルズ、エルエルシー 中枢神経システム及び/若しくは眼の細胞及び組織中の遺伝子の特異的阻害のための手段と方法
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
US20060030534A1 (en) 2002-09-04 2006-02-09 Gabriele Dorn Treatment of neurological disorders by dsrna administration
US20100183638A1 (en) * 2007-03-05 2010-07-22 Gowen Brian B Restrictive agonist of toll-like receptor 3 (tlr3)
EP2361306A1 (en) 2008-12-04 2011-08-31 OPKO Ophthalmics, LLC Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
DE3854829D1 (de) 1996-02-08
KR890003402A (ko) 1989-04-14
FI883763A0 (fi) 1988-08-12
ZA885967B (en) 1989-07-26
CN1050995C (zh) 2000-04-05
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31
DE3854829T2 (de) 1996-08-14
IL87413A0 (en) 1989-01-31
EP0308066A2 (en) 1989-03-22
AU1001595A (en) 1995-02-23
DK449888D0 (da) 1988-08-11
IE72103B1 (en) 1997-03-12
HUT47854A (en) 1989-04-28
PT88266A (pt) 1989-06-30
ATE132041T1 (de) 1996-01-15
PT88266B (pt) 1995-05-04
CA1327002C (en) 1994-02-15
EP0308066B1 (en) 1995-12-27
RU1834663C (ru) 1993-08-15
NZ225799A (en) 1991-04-26
CN1032740A (zh) 1989-05-10
JPH01131119A (ja) 1989-05-24
DK449888A (da) 1989-02-13
FI883763A (fi) 1989-02-13
NO883594L (no) 1989-02-13
AU1736792A (en) 1992-07-30
AU2053588A (en) 1989-04-20
EP0308066A3 (en) 1991-01-16
IE882399L (en) 1989-02-12

Similar Documents

Publication Publication Date Title
NO883594L (no) Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.
EP0400958A3 (en) Live vaccines
CA2173328A1 (en) HIV Protease Inhibitors
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
DK0652208T3 (da) Phenylalkan(en)syrer
JPS5519239A (en) Interferon-producing attractant
WHEELER et al. Influence of specific antibody on herpes simplex infections in tissue culture
Vignaux et al. Enhanced expression of histocompatibility antigens on interferon-treated mouse embryonic fibroblasts
NO920255D0 (no) Podofyllotoksinpreparat som inneholder triglyserider
ATE123625T1 (de) Herstellung von erhöhten biokontrollwirkstoffen.
SU571521A1 (ru) Способ термической обработки листовых деталей
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
Horsch et al. Infectious factorial diseases of farm animals.
JPS5639098A (en) Novel oligosaccharide and its preparation
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
JPS5492680A (en) Novel microorganism
IT1234390B (it) Prodotti microbici ottenuti mediante la coltivazione do achromobacter stenohalis, per combattere malattie virali
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.
AU4849897A (en) Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
TH7959EX (th) กรรมวิธีสำหรับการผลิตแอล-ธรีโอไนน์ ด้วยการหมัก